How Innovations in Drug-eluting Stents & Balloons Are Shaping the Peripheral Vascular Devices Industry
Frost & Sullivan Podcasts
Peripheral artery disease (PAD) affects more than 200 million people worldwide—yet many remain undiagnosed until it’s too late. As the burden of PAD rises, innovation in vascular care is accelerating. In this episode of Frost & Sullivan’s Growth Podcast, we explore how drug-eluting stents, drug-coated balloons, and bioresorbable scaffolds are reshaping the peripheral vascular devices industry.
From FDA-approved breakthroughs like Abbott’s Esprit BTK scaffold to next-generation imaging and robotic-assisted procedures, we break down the technologies, market forces, and competitive dynamics driving growth from $4.33 billion in 2024 to $6.06 billion by 2029.
Whether it’s improving long-term outcomes for below-the-knee interventions, transforming chronic limb-threatening ischemia treatment, or expanding minimally invasive options in outpatient care, this new wave of innovation is redefining patient care and unlocking significant growth opportunities.
Join us as we discuss the future of PAD management, the companies leading the charge, and the challenges that must be overcome to bring these solutions to patients worldwide.
For more insights on how your organization can lead the next era of vascular care, contact us at hello@frost.com
.
Loading